IM Cannabis (IMCC) Total Current Liabilities (2019 - 2026)
IM Cannabis (IMCC) recorded quarterly Total Current Liabilities of $20.2 million in Q1 2026, down 17.11% quarter-over-quarter from $24.4 million in Q4 2025, and down 28.9% on a YoY basis from $28.4 million in Q1 2025.
IM Cannabis (IMCC) Total Current Liabilities (2019 - 2026) Analysis & Trends
IM Cannabis' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $20.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 28.9% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $20.2 million (down 28.9% YoY), while the FY2025 annual figure was $24.4 million, down 4.39% from the prior year.
- Total Current Liabilities was $20.2 million for Q1 2026 at IM Cannabis, down from $24.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $53.1 million in Q3 2022 to a low of $19.3 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $28.0 million across 5 years, with a median of $24.9 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities sank 60.66% in 2023, then surged 37.75% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $24.9 million in 2022, then retreated by 3.16% to $24.1 million in 2023, then rose by 3.6% to $25.0 million in 2024, then retreated by 2.44% to $24.4 million in 2025, then fell by 17.11% to $20.2 million in 2026.
- The last three Total Current Liabilities figures came in at $20.2 million (Q1 2026), $24.4 million (Q4 2025), and $27.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | 20.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.21 Mn |
| Dec 31, 2025 | 24.39 Mn |
| Sep 30, 2025 | 27.95 Mn |
| Jun 30, 2025 | 25.37 Mn |
| Mar 31, 2025 | 28.43 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Sep 30, 2024 | 28.77 Mn |
| Jun 30, 2024 | 24.42 Mn |
| Mar 31, 2024 | 22.62 Mn |
| Dec 31, 2023 | 24.13 Mn |
| Sep 30, 2023 | 20.89 Mn |
| Jun 30, 2023 | 20.92 Mn |
| Mar 31, 2023 | 19.25 Mn |
| Dec 31, 2022 | 24.91 Mn |
| Sep 30, 2022 | 53.09 Mn |
| Jun 30, 2022 | 42.01 Mn |
| Mar 31, 2022 | 43.51 Mn |
| Dec 31, 2021 | 22.38 Mn |
| Dec 31, 2020 | 4.81 Mn |
| Dec 31, 2019 | 1.98 Mn |